J Vet Sci. 2020 Jul;21(4):e57. English.
Published online Jun 26, 2020.
© 2020 The Korean Society of Veterinary Science
Original Article

Molecular subtyping and antimicrobial susceptibility of Streptococcus dysgalactiae subspecies equisimilis isolates from clinically diseased pigs

Sang-Ik Oh,1,2, Jong Wan Kim,1 Jongho Kim,1 Byungjae So,1 Bumseok Kim,2 and Ha-Young Kim1
    • 1Animal Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Korea.
    • 2College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Korea.
Received January 31, 2020; Revised April 13, 2020; Accepted April 16, 2020.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Streptococcus dysgalactiae subspecies equisimilis (SDSE) acts as an etiological agent for lameness, neurological signs, and high mortality in pigs. Despite its importance in pig industries and zoonotic potential, little is known about the effects of this pathogen.

Objectives

This study aimed to determine the molecular characteristics and antimicrobial resistance of SDSE strains isolated from diseased pigs.

Methods

A total 11 SDSE isolates were obtained from diseased pigs. Bacterial identification, PCR for virulence genes, emm typing, and antimicrobial resistance genes, multilocus sequence typing, and antimicrobial susceptibility test were performed.

Results

Nine isolates were from piglets, and 8 showed lameness, sudden death, or neurological signs. The isolates were PCR-positive for sla (100%), sagA (100%), and scpA (45.5%), and only 1 isolate amplified the emm gene (stL2764). Eight different sequence types were detected, categorized into 2 clonal complexes and 4 singletons. All the isolates in this study were included in a small cluster, which also contained other strains derived from humans and horses. The minimum inhibitory concentrations for the tested beta-lactams were low, while those for macrolides, tetracyclines, and fluoroquinolones were relatively high. PCR analysis of the macrolide and tetracycline resistance genes demonstrated that the isolates carried erm(B) (18.2%, n = 2), mef(A/E) (9.1%, n = 1), tet(M) (18.2%, n = 2), and tet(O) (90.2%, n = 10). Two isolates presented a mutation in parC, which is associated with fluoroquinolone resistance.

Conclusion

This study provided insight into swine-derived SDSE, as it is related to veterinary medicine, and elucidated its zoonotic potential, in the context of molecular epidemiology and antimicrobial resistance in public health.

Keywords
Drug resistance; multilocus sequence typing; Streptococcus dysgalactiae subspecies equisimilis; swine; virulence

INTRODUCTION

Streptococcus dysgalactiae subspecies equisimilis (SDSE), which is a pyogenic pathogen belonging to Lancefield groups C, G, A, or L, has been recovered increasingly from severe invasive human infections worldwide [1, 2]. SDSE infection in humans can cause a broad spectrum of diseases, including skin abscess, cellulitis, pharyngitis, arthritis, bacteremia, endocarditis, and toxic shock syndrome [1]. Due to the severity of SDSE infection in humans, studies for the molecular characterization and zoonotic potential of this bacterium derived from animal hosts are of great interest [2, 3, 4, 5, 6]. However, most studies on SDSE isolated from animals have been limited to horses, and only few studies have addressed swine-derived SDSE isolates [7, 8, 9, 10].

Although SDSE is a member of the normal flora in pigs, it is considered an important beta-hemolytic Streptococcus, especially in piglets [11]. Vaginal secretions and milk from postparturient sows and contaminated floor surfaces, which are abrasive and harmful to the feet, are the most likely sources of infection in pigs [11, 12]. Our recent findings highlighted the importance of management of floor surfaces in farrowing pens, especially for neonatal piglets [10]. SDSE infection in pigs could cause septicemia, arthritis, endocarditis, or meningitis, which extensively overlap with the symptoms of SDSE infection in humans [11, 13]. Previous studies have suggested that the incidence and severity of invasive SDSE infections in humans have some relationship with several bacterial virulence factors, whereas the relationship in pigs is yet to be investigated [13]. As recent studies warn that SDSE may have the potential of zoonotic infections, the possibility of pig-to-human infection could increase in individuals who work in direct contact with pig or raw meat [5, 6]. Therefore, it is vital to elucidate the possibility of SDSE crossing the pig-to-human interspecies barrier using epidemiological approaches. In addition, pigs with a streptococcal infection, including SDSE infections, are widely treated by antimicrobial therapy [11]. Given that SDSE isolates from pigs may be zoonotic pathogens, it is important to survey their antimicrobial resistance genotypes and phenotypes to prepare for a potential public health hazard.

Here, we present the analysis of clinical features, molecular characteristics, and antimicrobial resistance of SDSE isolates from clinically diseased pigs. Through this study, we provide valuable information to improve awareness and understanding of SDSE infection in pigs and its zoonotic potential.

MATERIALS AND METHODS

Samples and bacterial isolation

In total, 11 SDSE isolates were obtained from clinically diseased pigs, which were submitted to the Animal and Plant Quarantine Agency of Korea for disease diagnosis from 2008 to 2017. The clinical features of these cases are summarized in Table 1. Briefly, the pigs were aged 3–70 days, with an average age of 32.5 days. Most cases (8 cases, 72.7%) showed at least one of the following clinical signs: lameness, neurological signs, or sudden death. Bacterial culture and virus detection were performed on the selected samples corresponding to the clinical symptoms of each case. Suspected beta-hemolytic Streptococcus grown on blood agar plate from each case were recovered from lungs (n = 5), joints (n = 4), pericardium (n = 1), and peritoneal cavity (n = 1).

Table 1
Clinical features of the swine cases in this study

Bacterial identification

Candidate beta-hemolytic isolates were identified as SDSE using the VITEK 2 system (GP ID card; bioMérieux, France) and confirmed by 16S ribosomal RNA (rRNA) gene sequencing according to a previous study [14]. Lancefield serological group was determined for groups A, B, C, and G by a Strep Grouping Kit (Denka Seiken, Japan).

Polymerase chain reaction (PCR) assay for virulence genes and emm typing

To increase the sensitivity of PCR detection, pure SDSE isolates were inoculated in Todd-Hewitt broth (THB; Difco, USA) at 5% CO2, 37°C for 24 h. Briefly, 300 μL of incubated THB was pelleted by centrifugation at 10,600 g for 2 min, and the supernatant was discarded. Further, the pellet was incubated at 37°C for 30 min in 50 μL of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0), 10 μL of mutanolysin (3,000 U/μL, Sigma, USA), and 8 μL of hyaluronidase (30 mg/mL, Sigma). Subsequently, DNA extraction and purification were conducted using the QIAamp DNA Mini Kit (Qiagen, Germany) according to the manufacturer's instruction.

Presence of superantigenic (SAg) genes (speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa, smez, and speGdys) and other specific virulence genes (sla, sagA, scpA, slo, and ska) in the genome of the isolates were identified using previously published primers and protocols [15].

The emm typing was carried out using primers and conditions set by the Centers for Disease Control and Prevention (CDC) guidelines (https://www.cdc.gov/streplab/protocol-emm-type.html). The obtained sequences were compared to the sequences in the emm type database available on the CDC website (http://www2a.cdc.gov/ncidod/biotech/strepblast.asp).

Multilocus sequence typing (MLST)

MLST was performed by sequencing for 7 housekeeping genes (gki, gtr, murI, mutS, recP, xpt, and atoB). Unique sequences at each locus were assigned allele numbers, and the corresponding combination of the 7 allele numbers for each isolate was used to define the sequence type (ST) using the PubMLST database (http://pubmlst.org/sdysgalactiae/). Clonal complexes (CCs) were defined at the single-locus variant (SLV) level. Comparison among pigs and other hosts' isolates was achieved through analysis of previously published MLST data [2, 5, 6, 16, 17, 18]. An expansion of the goeBURST algorithm in Phyloviz software was used to generate the compilation of the minimum spanning tree (MST), reflecting possible relationships among pig-, dog-, horse-, and human-derived STs.

Antimicrobial susceptibility test

The minimum inhibitory concentration (MIC) was determined by the standard microbroth dilution method as recommended by the Clinical and Laboratory Standards Institute (CLSI VET01-A4, 2013) using Sensititre Standard Susceptibility MIC Plates BOPO6F (TREK Diagnostic Systems, USA). Streptococcus pneumoniae ATCC 49619 and Staphylococcus aureus ATCC 29213 were used as the quality control strains. Overall, 50% MIC (MIC50) and 90% MIC (MIC90) were determined for each antimicrobial agent.

Identification of antimicrobial resistance genes

Presence of genes commonly associated with erythromycin resistance (erm(A), erm(B), and mef(A/E)) and tetracycline resistance (tet(K), tet(L), tet(M), and tet(O)) was assessed by PCR using previously published primers and protocols [19]. Segments of gyrA and parC containing the quinolone resistance determining regions (QRDR) were amplified and sequenced using primers, as previously described [20]. A comparative analysis of sequences was conducted using MEGA software, version 5.0 (http://www.megasoftware.net). ClustalW was used to perform multiple alignments of the nucleotide or predicted amino acid sequences. The reference sequences of gyrA and parC (SDSE strain AC-2713, GenBank accession number: HE858529) were obtained from GenBank.

RESULTS

SDSE isolate identification

The characteristics of the 11 swine-derived SDSE isolates are shown in Table 2. Sequences obtained from the isolates using 16S rRNA sequencing presented 93.5%–100% similarity to the SDSE reference strain (GenBank accession number: CP002215). All 16S rRNA gene sequences (n = 11) were deposited in the GenBank database (accession numbers: KY986687–KY986697). All the isolates presented as Lancefield group C antigens.

Table 2
Phenotypic and genotypic characteristics of SDSE isolates from clinically diseased pigs

Distribution of virulence genes and emm typing

All the isolates showed an identical virulence gene profile, except for scpA gene; PCR-negative for slo, ska, and all the tested SAg genes (speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa, smez, and speGdys ), while PCR-positive for sla and sagA. However, only 5 isolates (45.5%) carried the scpA (Table 2). Among the 11 isolates, emm gene was successfully amplified in only 1 isolate from case number 1 (KY986697), which typed as stL2764 (Table 3).

Table 3
Molecular epidemiological characteristics of SDSE isolates from clinically diseased pigs

MLST analysis

MLST performed for all the 11 SDSE isolates yielded 8 STs. Among them, 6 isolates included previously published STs, specifically ST315 (n = 3, 27.3%), ST252 (n = 2, 18.2%), and ST234 (n = 1, 9.1%) (Table 3). Five other isolates were identified as novel STs, which were assigned as ST336, ST337, ST338, ST339, and ST340. MLST sequences alignment revealed 2 novel sequences in mutS and xpt, which were designated as mutS41 and xpt71, respectively (Table 3). The STs were categorized into 2 CCs and 4 singletons at the SLV level. Among them, CC315/336 was the most prevalent (n = 4, 36.4%), followed by CC252/339 (n = 3, 27.3%). The MST, showing the relationships between STs, indicated that most STs were categorized according to their host of origin (Fig. 1). Three clusters (cluster A, B, and C) could be defined corresponding to a difference of at least 6 different loci. Cluster A and C consisted almost exclusively of human and horse isolates, respectively, from previous studies [2, 5, 6, 16, 17, 18]. Cluster B was composed of the swine-derived isolates from this study (n = 11) and human- (n = 4) and horse-derived (n = 5) isolates from previous studies [2, 16].

Fig. 1
Minimum spanning tree based on sequence types of 494 Streptococcus dysgalactiae subspecies equisimilis strains isolated from humans, horses, pigs, and dogs. The size of each circle is proportional to the number of isolates with that particular sequence type on a logarithmic scale. Numbers on branches represent the number of loci that differ from the founder sequence type.

Antimicrobial susceptibility of SDSE isolates

The MIC value distribution, MIC50, and MIC90 of the SDSE isolates against 10 tested antimicrobials are shown in Table 4. Beta-lactams (ampicillin, ceftiofur, and penicillin) showed the lowest MIC values for all the isolates, while tetracyclines (chlortetracycline and oxytetracycline) and danofloxacin presented the highest MIC values in the tested range of concentrations, for all the isolates. The MIC50 and MIC90 values of the isolates were identical for each tested antimicrobials in this study.

Table 4
MIC value distribution, MIC50, and MIC90 of SDSE strains from clinical diseased pigs against the tested antimicrobials

Identification of antimicrobial resistance genes

The distribution of macrolide and tetracycline resistance genes, as well as mutation in QRDR of GyrA and ParC, encoded by gyrA and parC, respectively, is shown in Table 5. Only 1 (9.1%) and 2 (18.2%) macrolide-resistant isolates contained mef(A/E) and erm(B), respectively. No isolate contained erm(A). Among the tested tetracycline resistance genes, tet(M) and tet(O) were found in 2 (18.2%) and 10 isolates (90.9%), respectively. No isolates had substitutions in GyrA, and only 2 isolates showed substitution in ParC: Glu96 to Asp and Ser79 to Phe.

Table 5
Distribution of antimicrobial resistance genes and gyrA, gyrB mutation of SDSE isolates from clinically diseased pigs

DISCUSSION

SDSE is known to cause sporadic septicemia and arthritis in suckling pigs, endocarditis in growing pigs, and ascending uterine infection in sows [10, 21]. As for age distribution, most SDSE-infected pigs in this study were suckling (≤ 21-day-old, n = 5) or weaning (≤ 60-day-old, n = 5) piglets. The result is consistent with a previous study suggesting that SDSE infection is usually seen in piglets [11]. Interestingly, no other systemic infectious pathogen, except for SDSE, was found in piglets below 10 days of age, implying that even a single SDSE infection can lead to sudden death or lameness in neonatal piglets.

All the isolates in this study belonged to the Lancefield group C. Although Katsumi et al. [22] reported that only 59.0% of SDSE strains isolated from slaughtered pigs belonged to Lancefield group C, our finding showed a trend similar to that of other previous studies, wherein group C was the most predominant strain in pigs [22, 23]. Conversely, the majority of human-recovered SDSE isolates from previous studies have been categorized as Lancefield group G [15, 24]. This discrepancy could be due to the heterogeneity of streptococci possessing Lancefield group C and G cell wall carbohydrates, in regards to the predilection for host species and clinical diseases produced in animals and humans [25].

In this study, the distribution of virulence genotype obtained from swine SDSE isolates was inconsistent in comparison with that from previous studies on human SDSE strains, which harbored some of the SAg genes [15, 26, 27, 28]. Further, most human SDSE strains in previous studies contained slo and ska, which were not found in this study [15, 26, 27, 28, 29]. Notably, all the swine isolates in this study harbored the sla gene, which is associated with epithelial cells, while this gene was not found in human-derived SDSE isolates from previous studies [15, 25, 28]. This suggests that SDSE could transfer between humans and animals to acquire specific virulence genes for binding to epithelial cells in each host [3]. Considering the zoonotic potential of SDSE, virulence genes in animal-derived strains should be closely monitored because the pathogen, which showed similarity with Streptococcus pyogenes, might cause serious human infections in the near future. Furthermore, the challenge trials of SDSE strains in pigs are needed to improve our understanding of this bacterium and to determine which virulence genes play a role in pathogenesis.

The M protein, encoded by emm gene, is also an important virulence factor, which prevents phagocytosis in the host [1]. Many studies have used emm typing for epidemiological investigation of SDSE isolates from humans [17, 18, 24, 30]. Some reports suggested that certain emm types from human SDSE strains are associated with antimicrobial resistance, while others are associated with severe infection [14, 24, 31]. However, this hypothesis may be applicable only for SDSE isolates from human sources, given that the isolates from animal sources are often emm non-typable [2]. Although our study could not find any associations due to typing of only 1 isolate, the amplified type (stL2764) in this study has already been documented in several surveys of the pig, human, and horse SDSE [2, 24, 32, 33]. Among them, Pinho et al. [2] strongly doubted that the horse isolate identified as stL2764 had zoonotic potential.

To elucidate swine potential for zoonotic transmission, the isolates were characterized using the MLST scheme. Our data showed that SDSE isolates from pigs in Korea had low genetic diversity, since most STs were linked at the SLV level and all were related at the triple-locus-variant level. MST analysis showed that all STs from pigs in this study were included in cluster B, which was separated from cluster A and C by a difference of at least 6 different loci. These findings indicated the existence of genetically related strains (included in cluster B), which could be isolated from humans, horses, and pigs. Taken together, these results suggest that swine-derived SDSE strains, all belonging to MLST-defined cluster B, have the potential to be zoonotic pathogens. However, the sample size of this study was too small to draw a general conclusion. Therefore, further studies with large numbers of SDSE isolates from both pigs and other diverse animal hosts are required to verify the infectious capacity of swine-derived SDSE strains in a wide range of hosts, including humans or a host-specific genomovar among SDSE from animals.

In the absence of effective vaccination against groups C or L streptococci, appropriate and accurate usage of antimicrobials has enabled veterinarians to combat SDSE infection in pigs [11]. Despite the limited information about antimicrobial susceptibility of swine-derived isolates, a recent study presented alarming MIC50 and MIC90 for most tested antimicrobials [9]. The results of this study confirmed beta-lactams as the best choice for treatment, which is consistent with previous studies in pigs and humans [9, 11, 15]. In this study, macrolides, tetracyclines, and danofloxacin showed the highest MIC50 and MIC90 values among the tested dilution ranges, suggesting these antimicrobials were not suitable for treating SDSE-infected pigs. These results were also consistent with a previous study on swine-derived SDSE from Brazil, yet inconsistent with human-derived SDSE from Korea, which showed the lowest MIC50 value against erythromycin (≤ 0.12 µg/mL) [9, 31]. Therefore, our findings serve as a crucial warning for public health because humans showing tonsillopharyngitis as a result of SDSE infection, who are allergic to beta-lactams, are usually treated with macrolides as an alternative antimicrobial therapy; if this treatment does not have positive response for the patients, tetracyclines and fluoroquinolones should be considered as a second choice [34].

The resistance genes of macrolides, tetracyclines, and fluoroquinolones were examined to investigate the genetic variation. To the best of our knowledge, there have been no previous attempts to survey antimicrobial resistance genes of SDSE from animal-species, despite the risk of possible transfer of resistant strains from animals to humans. We found that the results of this study (erm(A): 0%, erm(B): 18.2%, and mef(A/E): 9.1%) were similar to that of a previous study on human-recovered SDSE in Korea (erm(A): 4.3%, erm(B): 20.3%, and mef(A): 8.7%), which differed from previous studies from China (erm(A): 0%, erm(B): 78.6%, and mef(A/E): 5.4%) and Japan (erm(A): 15.5%, erm(B): 11.3%, and mef(A): 2.8%) [15, 30]. Of tetracycline resistance genes, the results (tet(M): 18.2%, tet(O): 90.9%) differed from previous studies in China and Korea, wherein the tet(M) gene (China: 73.2% and Korea: 29.0%) was more predominant than the tet(O) gene (China: 5.4% and Korea: 1.4%) in human-derived SDSE isolates [15, 30]. Mutations in the QRDR of gyrA or parC are known as a major mechanism of fluoroquinolone resistance. In this study, 2 isolates had a single amino acid substitution in ParC: Glu96 to Asp and Ser79 to Phe. Notably, a position mutation at Ser79 to Phe in parC has been found frequently in SDSE from humans [15, 30]. Given that the mutations in both gyrA and parC are associated with high-level resistance against fluoroquinolones, continuous monitoring of the QRDR in swine-derived SDSE isolates is needed to detect emerging fluoroquinolone resistant strains [15]. The discrepancy between the observed phenotypic and genotypic antimicrobial resistance in this study could be explained by a previous study, which suggested that the possession of antimicrobial resistance genes does not always accurately reflect the bacterial resistance phenotype [35]. Taken together, SDSE isolates from clinically diseased pigs had only slightly different distribution of antimicrobial resistance genes of macrolides, tetracyclines, and fluoroquinolones from that of humans. Thus, more prudent use of antimicrobials, especially macrolides, tetracyclines, and fluoroquinolones, is recommended in veterinary medicine.

In conclusion, our findings suggest that SDSE should be considered as an important pathogen in piglets, which could cause lameness, neurological signs, and sudden death. Analysis of virulence genes differed from previous studies on human isolates in distribution of sla, slo, and ska genes. Based on our epidemiological studies, we provide evidence supporting the previously proposed hypothesis that several specific SDSE may have zoonotic potential. Moreover, SDSE from pigs in this study presented alarming MIC values for macrolides, tetracyclines, and fluoroquinolones, which are often used as alternatives to beta-lactams in human-infected SDSE. Thus, further studies with a large number of strains are essential to clarify the zoonotic potential of SDSE from diverse animal populations.

Notes

Funding:This work was supported by the Animal and Plant Quarantine Agency, Ministry of Agriculture, Food, and Rural Affairs of the Republic of Korea.

Conflict of Interest:The authors have no conflicts of interest to declare.

Author Contributions:

  • Conceptualization: Oh SI, Kim HY.

  • Data curation: Oh SI, Kim J, Kim HY.

  • Formal analysis: Oh SI.

  • Funding acquisition: Kim JW, So B.

  • Investigation: Oh SI, Kim HY.

  • Methodology: Oh SI, Kim J, Kim HY.

  • Project administration: Kim JW, So B.

  • Resources: Kim HY.

  • Software: Oh SI.

  • Supervision: Kim HY, Kim B.

  • Validation: Kim HY.

  • Visualization: Oh SI.

  • Writing - original draft: Oh SI

  • Writing - review & editing: Kim HY, Kim B.

References

    1. Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis 2009;49(5):766–772.
    1. Pinho MD, Erol E, Ribeiro-Gonçalves B, Mendes CI, Carriço JA, Matos SC, et al. Beta-hemolytic Streptococcus dysgalactiae strains isolated from horses are a genetically distinct population within the Streptococcus dysgalactiae taxon. Sci Rep 2016;6:31736.
    1. Ciszewski M, Szewczyk EM. Potential factors enabling human body colonization by animal Streptococcus dysgalactiae subsp. equisimilis strains. Curr Microbiol 2017;74(5):650–654.
    1. Preziuso S, Pinho MD, Attili AR, Melo-Cristino J, Acke E, Midwinter AC, et al. PCR based differentiation between Streptococcus dysgalactiae subsp. equisimilis strains isolated from humans and horses. Comp Immunol Microbiol Infect Dis 2014;37(3):169–172.
    1. Schrieber L, Towers R, Muscatello G, Speare R. Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community. Zoonoses Public Health 2014;61(2):145–148.
    1. Silva LG, Genteluci GL, Corrêa de Mattos M, Glatthardt T, Sá Figueiredo AM, Ferreira-Carvalho BT. Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage. J Med Microbiol 2015;64(Pt 5):551–558.
    1. Kasuya K, Yoshida E, Harada R, Hasegawa M, Osaka H, Kato M, et al. Systemic Streptococcus dysgalactiae subspecies equisimilis infection in a Yorkshire pig with severe disseminated suppurative meningoencephalomyelitis. J Vet Med Sci 2014;76(5):715–718.
    1. Kawata K, Minakami T, Mori Y, Katsumi M, Kataoka Y, Ezawa A, et al. rDNA sequence analyses of Streptococcus dysgalactiae subsp. equisimilis isolates from pigs. Int J Syst Evol Microbiol 2003;53(Pt 6):1941–1946.
    1. Moreno LZ, da Costa BL, Matajira CE, Gomes VT, Mesquita RE, Silva AP, et al. Molecular and antimicrobial susceptibility profiling of Streptococcus dysgalactiae isolated from swine. Diagn Microbiol Infect Dis 2016;86(2):178–180.
    1. Oh SI, Kim JW, Jung JY, Chae M, Lee YR, Kim JH, et al. Pathologic and molecular characterization of Streptococcus dysgalactiae subsp. equisimilis infection in neonatal piglets. J Vet Sci 2018;19(2):313–317.
    1. Gottschalk M. Streptococcosis. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, editors. Disease of Swine. 10th ed. Ames: John Wiley & Sons, Inc.; 2012. pp. 841-855.
    1. Zoric M, Sjölund M, Persson M, Nilsson E, Lundeheim N, Wallgren P. Lameness in piglets. Abrasions in nursing piglets and transfer of protection towards infections with Streptococci from sow to offspring. J Vet Med B Infect Dis Vet Public Health 2004;51(6):278–284.
    1. Lother SA, Demczuk W, Martin I, Mulvey M, Dufault B, Lagacé-Wiens P, et al. Clonal clusters and virulence factors of group C and G Streptococcus causing severe infections, Manitoba, Canada, 2012–2014. Emerg Infect Dis 2017;23(7):1079–1088.
    1. Tanaka D, Isobe J, Watahiki M, Nagai Y, Katsukawa C, Kawahara R, et al. Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen. J Clin Microbiol 2008;46(4):1526–1529.
    1. Lu B, Fang Y, Huang L, Diao B, Du X, Kan B, et al. Molecular characterization and antibiotic resistance of clinical Streptococcus dysgalactiae subsp. equisimilis in Beijing, China. Infect Genet Evol 2016;40:119–125.
    1. Ahmad Y, Gertz RE Jr, Li Z, Sakota V, Broyles LN, Van Beneden C, et al. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol 2009;47(7):2046–2054.
    1. McMillan DJ, Bessen DE, Pinho M, Ford C, Hall GS, Melo-Cristino J, et al. Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination. PLoS One 2010;5(7):e11741
    1. McMillan DJ, Kaul SY, Bramhachari PV, Smeesters PR, Vu T, Karmarkar MG, et al. Recombination drives genetic diversification of Streptococcus dysgalactiae subspecies equisimilis in a region of streptococcal endemicity. PLoS One 2011;6(8):e21346
    1. Malhotra-Kumar S, Lammens C, Piessens J, Goossens H. Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob Agents Chemother 2005;49(11):4798–4800.
    1. Kawamura Y, Fujiwara H, Mishima N, Tanaka Y, Tanimoto A, Ikawa S, et al. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob Agents Chemother 2003;47(11):3605–3609.
    1. Pérez-Sancho M, Vela AI, García-Seco T, González S, Domínguez L, Fernández-Garayzábal JF. Usefulness of MALDI-TOF MS as a diagnostic tool for the identification of Streptococcus species recovered from clinical specimens of pigs. PLoS One 2017;12(1):e0170784
    1. Katsumi M, Kataoka Y, Takahashi T, Kikuchi N, Hiramune T. Biochemical and serological examination of beta-hemolytic streptococci isolated from slaughtered pigs. J Vet Med Sci 1998;60(1):129–131.
    1. Vecht U, van Leengoed LA, Verheijen ER. Streptococcus suis infections in pigs in the Netherlands (Part I). Vet Q 1985;7(4):315–321.
    1. Loubinoux J, Plainvert C, Collobert G, Touak G, Bouvet A, Poyart C, et al. Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010. J Clin Microbiol 2013;51(8):2724–2727.
    1. Baracco GJ, Bisno AL. Group C and group G streptococcal infections: epidemiologic and clinical aspects. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, editors. Gram-Positive Pathogens. 2nd ed. Washington, D.C.: American Society of Microbiology; 2006. pp. 222-229.
    1. Ikebe T, Murayama S, Saitoh K, Yamai S, Suzuki R, Isobe J, et al. Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan. Epidemiol Infect 2004;132(1):145–149.
    1. Tsai CT, Chi CY, Ho CM, Lin PC, Chou CH, Wang JH, et al. Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia. J Microbiol Immunol Infect 2014;47(6):462–468.
    1. Yamaguchi Y, Yamaguchi T, Fukushima S, Nakamura I, Imura R, Harada Y, et al. Clinical and bacteriological investigation of Streptococcus dysgalactiae subsp. equisimilis infections treated at Tokyo Medical University Hospital. J Tokyo Med Univ 2017;75(2):208–218.
    1. Sitkiewicz I, Nagiec MJ, Sumby P, Butler SD, Cywes-Bentley C, Musser JM. Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc Natl Acad Sci U S A 2006;103(43):16009–16014.
    1. Wajima T, Morozumi M, Hanada S, Sunaoshi K, Chiba N, Iwata S, et al. Molecular characterization of invasive Streptococcus dysgalactiae subsp. equisimilis, Japan. Emerg Infect Dis 2016;22(2):247–254.
    1. Kim S, Byun JH, Park H, Lee J, Lee HS, Yoshida H, et al. Molecular epidemiological features and antibiotic susceptibility patterns of Streptococcus dysgalactiae subsp. equisimilis isolates from Korea and Japan. Ann Lab Med 2018;38(3):212–219.
    1. Srifuengfung S, Tribuddharat C, Sapcharoen S, Nitayanon P. Prevalence of the M protein gene in group C and group G streptococci isolated from patients in Thailand. Jpn J Infect Dis 2017;70(1):108–110.
    1. Yoshida H, Matsui H, Murayama SY, Takada Y, Matsuo K, Takahashi T, et al. A CD46 transgenic mouse model for studying the histopathology of arthritis caused by subcutaneous infection with Streptococcus dysgalactiae subspecies equisimilis . J Med Microbiol 2011;60(Pt 12):1860–1868.
    1. Savini V, Catavitello C, Talia M, Manna A, Pompetti F, Di Bonaventura G, et al. β-Lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis Pharyngitis patients. J Clin Microbiol 2008;46(2):814–816.
    1. Smith M, Do TN, Gibson JS, Jordan D, Cobbold RN, Trott DJ. Comparison of antimicrobial resistance phenotypes and genotypes in enterotoxigenic Escherichia coli isolated from Australian and Vietnamese pigs. J Glob Antimicrob Resist 2014;2(3):162–167.

Metrics
Share
Figures

1 / 1

Tables

1 / 5

PERMALINK